-
cds.ahrq.gov/sites/default/files/workgroups/1131/CDS%20Connect%20Work%20Group%20March%202020%20Meeting%20Slides.pdf
March 01, 2020 - FHIR and CCL Call, MSH
FHIR and UX
Display • Clear indication that this dynamic calculator does NOT
-
cds.ahrq.gov/cedar/AHRQ_CEDAR_Contribution_Agreement_508.pdf
September 28, 2022 - AHRQ CEDAR Contribution Agreement
Contributing
Thank you for your interest in contributing to the open source CEDAR project! We welcome
all friendly contributions, including:
• bug reports
• comments and suggestions
• feature requests
• bug fixes
• feature implementations and enhancements
• documentation …
-
cds.ahrq.gov/sites/default/files/workgroups/1251/CDS_Connect_WG_Jan2021_Summary.pdf
January 21, 2021 - CDS Connect Work Group Meeting Summary 1-21-2021
CDS (Clinical Decision Support) Connect Work Group
Meeting Summary
January 21, 2021
3:00 – 4:00 pm ET
Attendees: 52 people (48 attendees + 4 call-ins)
Organization Attendee Names
AHRQ Members Steve Bernstein, Roland Gamache, Ed Lomotan, Mario Terán (…
-
cds.ahrq.gov/sites/default/files/cds/artifact/logic/2023-10/hook.json
January 01, 2023 - {
"hook": "patient-view",
"title": "CTPA order check",
"description": "CTPA order check cds hook",
"id": "pe",
"prefetch": {
"patient": "Patient/{{context.patientId}}",
"wells": "Observation?subject={{context.patientId}}&code=http://loinc.org|89547-4",
"ddimer": "Observation?subject={{cont…
-
cds.ahrq.gov/cedar/AHRQ_CEDAR_Final_Pilot_Report_October_2022_508.pdf
January 01, 2022 - AHRQ CEDAR Final Pilot Report
AHRQ CEDAR
Final Pilot Report
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD 20857
www.ahrq.gov
Contract No. 75FCMC18D0047
Prepared by:
CMS Alliance to Modernize Healthcare (The Health FFRDC)
A Federally Funded Research and Development Center …
-
cds.ahrq.gov/sites/default/files/cds/artifact/1071/Implementation%20Guide_Healthful%20Diet%20and%20Physical%20Activity_Final.pdf
September 01, 2019 - or more abnormal lab result
value(s), since abnormal lab results alone may not provide an accurate indication … A result of >130 mg/dL is an indication of
dyslipidemia. … A result of <40 mg/dL is an indication of
dyslipidemia.
-
cds.ahrq.gov/sites/default/files/workgroups/226/mar-2017-cholesterol-wg-notes.docx
January 01, 2017 - Title of document or resource
Repository Work Group
Meeting Summary
Date
03/08/2017
Time
1:30 – 3:30 PM ET
AGENDA
· Clarify Details Related to Existing Artifacts
· Logic exclusions, specification of conditions, lookback periods and the inclusion of parameters for scalar values
· Considerations for art…
-
cds.ahrq.gov/sites/default/files/cds/artifact/711/Anthrax_Post_Exposure_Prophylaxis_CDS_Validation_Report.pdf
October 17, 2018 - Either there is an indication that the recommended dosing
sequence was not followed (i.e., there is … populated, then the evaluators marked that entry in the form shown in Appendix A.1
with a “1” as an indication
-
cds.ahrq.gov/sites/default/files/workgroups/231/apr-2017-cholesterol-wg-notes.docx
January 01, 2017 - Cholesterol Management Work Group
Meeting Summary
Date
04/19/2017
Time
01:00 – 3:00 PM EST
AGENDA
· Welcome
· Brief Overview of Existing CDS Connect Artifacts
· Clarify Logic Details for USPTF-related Artifacts
· Discuss Best Approach for Transforming eCQM Specifications into CDS Logic
· Next Steps an…
-
cds.ahrq.gov/sites/default/files/workgroups/1176/CDS%20Connect%20Work%20Group%20May%202020%20Meeting%20Slides.pdf
May 01, 2020 - May 2020 CDS Connect Work Group Call
May 2020 CDS Connect Work Group Call
Agenda
Schedule Topic
• 3:00 – 3:02 • Roll Call, Michelle Lenox (MITRE)
• 3:02 – 3:05 • Review of the Agenda, Maria Michaels (CDC)
• 3:05 – 3:50 • CDS Artifact Review and Update across CDS Connect (MITRE)
• 3:50– 3:55 • What's New with …
-
cds.ahrq.gov/sites/default/files/cds/artifact/1066/2024_CDS_Connect_IG_Diabetes_Part_Two_Counseling_1.pdf
January 01, 2024 - delaying progression to
diabetes in certain populations but has not secured FDA approval for this indication
-
cds.ahrq.gov/sites/default/files/cds/artifact/1066/2023_CDS_Connect_IG_T2DM_Part_Two_Counseling_0.pdf
January 01, 2023 - delaying progression to diabetes in certain
19
populations but has not secured FDA approval for this indication
-
cds.ahrq.gov/sites/default/files/cds/artifact/logic/2023-10/CQL%20to%20CDS%20Hooks%20cards_0.txt
January 01, 2023 - Mapping of CQL conditions to CDS Hooks cards
Condition: NoDDimerNoWells
Card: It is recommended to assess the patient's risk for pulmonary embolism (PE) and evaluate D-dimer levels before proceeding with a CTPA order. Use the following link to evaluate the risk.
Launch Questionnaire: Yes
Condition: NoDDimerWellsLessT…
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_USPSTF%20Statin%20Use%20for%20the%20Primary%20Prevention%20of%20CVD%20in%20Adults_Final.docx
October 01, 2017 - Cholesterol Management Work Group recommendation based on their medical expertise), and active dialysis is an indication
-
cds.ahrq.gov/sites/default/files/cds/artifact/1066/Implementation%20Guide_Abnormal%20Blood%20Glucose%20and%20Type%202%20DM_Part%20Two%20Counseling_Final.pdf
September 01, 2019 - Implementation Guide: Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Part Two, Counseling
1
Implementation Guide
Abnormal Blood Glucose and Type 2 Diabetes
Mellitus: Part Two, Counseling
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD 20857
www.ahrq.gov
Contract No. HHSA29…
-
cds.ahrq.gov/sites/default/files/cds/artifact/711/Anthrax%20Post%20Exposure%20Prophylaxis%20Implementation%20Guide%20v2.0%2020190607.pdf
June 07, 2019 - If there is an indication that the patient
cannot tolerate a particular recommended treatment, an
-
cds.ahrq.gov/sites/default/files/cds/artifact/76/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making_Final_0.docx
October 01, 2017 - CDS Connect Implementation Guide Draft
Agency for Healthcare Research and Quality (AHRQ)
Agency for Healthcare Research and Quality (AHRQ)
Implementation Guide
Longitudinal ASCVD Risk Assessment Tool for Shared Decision Making
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Hu…
-
cds.ahrq.gov/sites/default/files/cds/artifact/1071/2024_CDS_Connect_IG_Healthy_Diet_Physical_Activity.pdf
January 01, 2024 - A result of >130 mg/dL is an indication of dyslipidemia. … A result of <40 mg/dL is an indication of dyslipidemia.
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Clinician%20Facing%20CDS%20Intervention.pdf
January 01, 2020 - A result of >130 mg/dL
is an indication of dyslipidemia, a risk factor for developing coronary artery … A result of <40 mg/dL is an indication of
dyslipidemia, a risk factor for developing CAD and stroke.
-
cds.ahrq.gov/sites/default/files/cds/artifact/1066/Implementation%20Guide%20Abnormal%20Blood%20Glucose%20and%20Type%202%20DM%20Counseling.pdf
September 01, 2021 - Implementation Guide: Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Part Two, Counseling
1
Implementation Guide
Abnormal Blood Glucose and Type 2 Diabetes
Mellitus: Part Two, Counseling
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD 20857
www.ahrq.gov
Contract No. 75FCMC…